Calquence + Venetoclax 1L CLL Patient Information Booklet
Patient information booklet for patients prescribed Calquence + Venetoclax for 1L CLL providing helpful information about CLL and Calquence therapy
Adverse events should be reported
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to AstraZeneca by visiting contactazmedical.astrazeneca.com or by calling 0800 783 0033.
September 2025 I GB-69434